Zim Laboratories Ltd.
BSE: 541400 | Sector: Health care |
NSE: N.A. | ISIN Code: INE518E01015 |
BSE 00:00 | 12 Aug | 213.95 |
10.45 (5.14%) |
OPEN
217.45 |
HIGH
217.45 |
LOW
203.55 |
NSE 05:30 | 01 Jan | Zim Laboratories Ltd Not listed in NSE |
OPEN | 217.45 |
PREVIOUS CLOSE | 203.50 |
VOLUME | 2364 |
52-Week high | 264.75 |
52-Week low | 109.10 |
P/E | 18.82 |
Mkt Cap.(Rs cr) | 347 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
About Zim Laboratories Ltd.
428407/02/96VATSALA Zim Laboratories Ltd --------------------------------------------------The Company was incorporated in the state of Maharashtra under the name and style of Zim Laboratories Pvt. Ltd. The company is engaged in manufacturing pharmaceutical products in the form of Tablets Capsules and Syrups. The Company became a Public Ltd. Company by passing speci...> More
Zim Laboratories Ltd - Key Fundamentals
Parameter | Values | ||
Market Cap | (![]() |
347 | |
EPS - TTM | (![]() |
[*S] | 11.37 |
P/E Ratio | (X) | [*S] | 18.82 |
Face Value | (![]() |
10 | |
Latest Dividend | (%) | 5.00 | |
Latest Dividend Date | 19 Sep 2019 | ||
Dividend Yield | (%) | 0.00 | |
Book Value / Share | (![]() |
[*S] | 104.73 |
P/B Ratio | (![]() |
[*S] | 2.04 |
Announcement
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
-
Board Meeting Intimation for Intimation Under Regulation 29 Of SEBI (Listing Obligations & Disclosur
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Statement Of Investor Complaints For The Quarter Ended June 2022
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Zim Laboratories Ltd - Financial Results
Particulars (![]() |
Jun 2022 | Jun 2021 | % Chg |
Net Sales | 92.75 | 64.17 | 44.54 |
Other Income | 1.89 | 1.22 | 54.92 |
Total Income | 94.64 | 65.4 | 44.71 |
Total Expenses | 81.56 | 58.9 | 38.47 |
Operating Profit | 13.08 | 6.49 | 101.54 |
Net Profit | 5.15 | 0.19 | 2610.53 |
Equity Capital | 16.24 | 16.24 | - |
Zim Laboratories Ltd - Peer Group
Company | Price(![]() |
Chg (%) | Mkt Cap (![]() |
Anuh Pharma | 90.95 | 0.83 | 455.84 |
Fredun Pharma | 929.40 | -0.06 | 413.58 |
Ind-Swift Labs. | 59.75 | 0.34 | 353.06 |
Zim Laboratories | 213.95 | 5.14 | 347.45 |
Zenotech Lab. | 56.25 | 0.45 | 343.29 |
Lyka Labs | 118.70 | -0.08 | 340.55 |
Natural Capsules | 541.55 | -1.50 | 337.39 |
Zim Laboratories Ltd - SHAREHOLDING PATTERN
|
|
Zim Laboratories Ltd - RETURNS
Period | BSE | NSE | Sensex | NIFTY |
1 Week | -1.99% | NA | 2.00% | 1.82% |
1 Month | 4.88% | NA | 10.35% | 10.21% |
3 Month | 12.61% | NA | 12.34% | 11.96% |
6 Month | 38.84% | NA | 2.25% | 1.86% |
1 Year | 48.63% | NA | 8.42% | 8.15% |
3 Year | 101.55% | NA | 58.22% | 59.30% |
Zim Laboratories Ltd - STOCK STRENGTH
Today's Low/High | 203.55 | 217.45 | |
Week Low/High | 195.50 | 236.00 | |
Month Low/High | 185.30 | 265.00 | |
YEAR Low/High | 109.10 | 265.00 | |
All TIME Low/High | 42.00 | 265.00 |
Quick Links for Zim Laboratories:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices